TY - JOUR

T1 - Moderate-to-high intensity physical exercise in patients with Alzheimer’s disease

T2 - a randomised controlled trial.

AU - Hoffmann, Kristine

AU - Sobol, Nanna A.

AU - Frederiksen, Kristian S.

AU - Beyer, Nina Ann-Marie

AU - Vogel, Asmus Mejling

AU - Vestergaard, Karsten

AU - Brændgaard, Hans

AU - Gottrup, Hanne

AU - Lolk, Annette

AU - Wermuth, Lene

AU - Jacobsen, Søren

AU - Laugesen, Lars P.

AU - Gergelyffy, Robert G.

AU - Høgh, Peter

AU - Bjerregaard, Eva

AU - Andersen, Birgitte Bo

AU - Siersma, Volkert Dirk

AU - Johannsen, Peter

AU - Cotman, Carl W

AU - Waldemar, Gunhild

AU - Hasselbalch, Steen

PY - 2016

Y1 - 2016

N2 - Background: Studies of physical exercise in patients with Alzheimer’s disease (AD) are few and results have been inconsistent.Objective: To assess the effects of a moderate-to-high intensity aerobic exercise program in patients with mild AD.Methods: In a randomized controlled trial, we recruited 200 patients with mild AD to a supervised exercise group (60-min sessions three times a week for 16 weeks) or to a control group. Primary outcome was changed from baseline in cognitive performance estimated by Symbol Digit Modalities Test (SDMT) in the intention-to-treat (ITT) group. Secondary outcomes included changes in quality of life, ability to perform activities of daily living, and in neuropsychiatric and depressive symptoms. Results: The ITT analysis showed no significant differences between intervention and control groups in change from baseline of SDMT, other cognitive tests, quality of life, or activities of daily living. The change from baseline in Neuropsychiatric Inventory differed significantly in favor of the intervention group (mean: –3.5, 95% confidence interval (CI) –5.8 to –1.3, p = 0.002). In subjects who adhered to the protocol, we found a significant effect on change from baseline in SDMT as compared with the control group (mean: 4.2, 95% CI 0.5 to 7.9, p = 0.028), suggesting a dose-response relationship between exercise and cognition.Conclusions: This is the first randomized controlled trial with supervised moderate-to-high intensity exercise in patients with mild AD. Exercise reduced neuropsychiatric symptoms in patients with mild AD, with possible additional benefits of preserved cognition in a subgroup of patients exercising with high attendance and intensity.

AB - Background: Studies of physical exercise in patients with Alzheimer’s disease (AD) are few and results have been inconsistent.Objective: To assess the effects of a moderate-to-high intensity aerobic exercise program in patients with mild AD.Methods: In a randomized controlled trial, we recruited 200 patients with mild AD to a supervised exercise group (60-min sessions three times a week for 16 weeks) or to a control group. Primary outcome was changed from baseline in cognitive performance estimated by Symbol Digit Modalities Test (SDMT) in the intention-to-treat (ITT) group. Secondary outcomes included changes in quality of life, ability to perform activities of daily living, and in neuropsychiatric and depressive symptoms. Results: The ITT analysis showed no significant differences between intervention and control groups in change from baseline of SDMT, other cognitive tests, quality of life, or activities of daily living. The change from baseline in Neuropsychiatric Inventory differed significantly in favor of the intervention group (mean: –3.5, 95% confidence interval (CI) –5.8 to –1.3, p = 0.002). In subjects who adhered to the protocol, we found a significant effect on change from baseline in SDMT as compared with the control group (mean: 4.2, 95% CI 0.5 to 7.9, p = 0.028), suggesting a dose-response relationship between exercise and cognition.Conclusions: This is the first randomized controlled trial with supervised moderate-to-high intensity exercise in patients with mild AD. Exercise reduced neuropsychiatric symptoms in patients with mild AD, with possible additional benefits of preserved cognition in a subgroup of patients exercising with high attendance and intensity.

U2 - 10.3233/JAD-150817

DO - 10.3233/JAD-150817

M3 - Journal article

C2 - 26682695

VL - 50

SP - 443

EP - 453

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -